SEC 13F Intelligence

Farrow Financial, Inc. / LLY

Farrow Financial, Inc.’s Eli Lilly & Co Position

Does Farrow Financial, Inc. own Eli Lilly & Co (LLY)? Yes2.5K shares worth $2M (+1.31% of its 13F portfolio) as of Q1 2026, down from 2.6K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
2.5K
% of Portfolio
+1.31%
Quarters Held
10
currently held

Position History LLY

Reported value by quarter
Q4 ’23: $1MQ4 ’23Q1 ’24: $2MQ2 ’24: $2MQ2 ’24Q3 ’24: $2MQ4 ’24: $2MQ4 ’24Q1 ’25: $2MQ2 ’25: $2MQ2 ’25Q3 ’25: $2MQ4 ’25: $3MQ4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20262.5K$2M+1.31%
Q4 20252.6K$3M+1.60%
Q3 20252.6K$2M+1.15%
Q2 20252.6K$2M+1.22%
Q1 20252.7K$2M+1.49%
Q4 20242.7K$2M+1.33%
Q3 20242.4K$2M+1.37%
Q2 20242.5K$2M+1.52%
Q1 20242.5K$2M+1.34%
Q4 20232.4K$1M+1.06%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Farrow Financial, Inc.’s full portfolio or all institutional holders of LLY.